BOLDMEDICINE Trademark

Trademark Overview

On Thursday, September 1, 2016, a trademark application was filed for BOLDMEDICINE with the United States Patent and Trademark Office. The USPTO has given the BOLDMEDICINE trademark a serial number of 87157954. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, July 17, 2024. This trademark is owned by Ovid Therapeutics Inc.. The BOLDMEDICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
boldmedicine

General Information

Serial Number87157954
Word MarkBOLDMEDICINE
Filing DateThursday, September 1, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, July 17, 2024
Registration Number5238290
Registration DateTuesday, July 4, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2017

Trademark Statements

Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2016
Primary Code042
First Use Anywhere DateThursday, December 8, 2016
First Use In Commerce DateThursday, December 8, 2016

Trademark Owner History

Party NameOvid Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001
Party NameOvid Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameOvid Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events

Event DateEvent Description
Monday, December 12, 2016NON-FINAL ACTION WRITTEN
Monday, September 5, 2016NEW APPLICATION ENTERED
Wednesday, September 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2016ASSIGNED TO EXAMINER
Monday, December 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2016NON-FINAL ACTION E-MAILED
Monday, January 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 12, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 4, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, April 20, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, April 20, 2017USE AMENDMENT FILED
Friday, May 12, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 15, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, May 29, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 30, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 4, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, September 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 4, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 17, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 17, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, July 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

boldmedicine development research pharmaceutical